<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Extraction extraction-result-116 - Theorizer</title>
    <link rel="stylesheet" href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/5.15.1/css/all.min.css">
    <link rel="stylesheet" href="../style.css">
</head>
<body>
    <div class="header">
        <a href="../index.html"><i class="fas fa-flask"></i> Theorizer</a>
    </div>

    <div class="content">
        <h1>Extracted Data Details for extraction-result-116</h1>

        <div class="section">
            <h2>Extracted Data (Header)</h2>
            <div class="info-section">
                <p><strong>Extraction ID:</strong> extraction-result-116</p>
                <p><strong>Extraction Schema Used (ID):</strong> <a href="../schemas/extraction-schema-5.html">extraction-schema-5</a></p>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <p><strong>Paper ID:</strong> paper-b6e5206470663efe0bc7d13e176f59d4d32b05b6</p>
                <p><strong>Paper Title:</strong> <a href="https://www.semanticscholar.org/paper/b6e5206470663efe0bc7d13e176f59d4d32b05b6" target="_blank">Lung cancer: epidemiology, etiology, and prevention.</a></p>
                <p><strong>Paper Venue:</strong> Clinics in Chest Medicine</p>
                <p><strong>Paper TL;DR:</strong> Modifiable risk factors, including tobacco smoking, occupational carcinogens, diet, and ionizing radiation are focused on, which can provide additional foundation for disease prevention.</p>
                <p><strong>Cost:</strong> 0.028</p>
            </div>
        </div>

        <div class="section">
            <h2>Extracted Data (Details)</h2>
            <div class="extraction-instance-container" id="e116.0">
                <h3 class="extraction-instance">Extracted Data Instance 0 (e116.0)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Genetic susceptibility (familial & GWAS/candidate genes)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Host genetic susceptibility: familial aggregation, high- and low-penetrance variants, GWAS loci and candidate gene polymorphisms</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The paper reviews evidence that inherited genetic factors (familial aggregation, rare high-penetrance syndromes, low-penetrance common variants identified by candidate-gene studies and GWAS) modify smokers' lung cancer risk, naming specific loci/genes and summarized effect sizes from meta-analyses and family studies.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>family aggregation studies, meta-analyses, candidate-gene association studies, GWAS (review synthesis)</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>Mixed populations reported across cited studies (familial aggregation and meta-analyses across multiple case-control and cohort studies; GWAS on histologically confirmed NSCLC cohorts; examples include white, Asian, and mixed-ancestry cohorts; some studies specific to female Han Chinese never-smokers noted).</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Generally mixed across studies cited; many adjusted for pack-years, smoking intensity, and smoking status (never/former/current), but no single uniform metric reported by the review for genetic studies.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Histologically confirmed lung cancer (NSCLC) or registry-ascertained cancer in the underlying studies cited; review summarizes associations across disparate case-control and cohort definitions.</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[{'gene_or_locus': 'GPC5 (13q31.3)', 'variant_rsID': None, 'direction_of_effect': 'risk allele associated with altered GPC5 expression and increased risk in a GWAS of never-smokers', 'association_context': 'reported in GWAS of lung cancer in never smokers (review mentions association)'}, {'gene_or_locus': 'CLPTM1L-TERT (5p15.33)', 'variant_rsID': None, 'direction_of_effect': 'risk alleles associated with increased risk (identified in GWAS of female Han Chinese never-smokers)', 'association_context': 'GWAS signal; implicated in carcinogenesis'}, {'gene_or_locus': 'CHRNA gene region (15q25.1; nicotinic acetylcholine receptor genes)', 'variant_rsID': None, 'direction_of_effect': 'risk locus for lung cancer susceptibility identified in GWAS', 'association_context': 'Amos et al. GWAS identified susceptibility locus at 15q25.1'}, {'gene_or_locus': 'CYP1A1 (Ile462Val discussed)', 'variant_rsID': None, 'direction_of_effect': 'mixed; pooled analysis found no overall association but a ~55% increased risk for squamous cell carcinoma in whites (esp. women and nonsmokers) in pooled analyses', 'association_context': 'candidate-gene meta-analysis with conflicting results'}, {'gene_or_locus': 'GSTM1 (null genotype)', 'variant_rsID': None, 'direction_of_effect': 'null associated with modest increased risk (~17% in earlier study; ~18% in large meta-analysis), but association attenuated in analyses restricted to larger studies', 'association_context': 'candidate-gene meta-analyses'}, {'gene_or_locus': 'mEH/EPHX1, NAT2, MPO, NQO1, GSTT1', 'variant_rsID': None, 'direction_of_effect': 'variants in these metabolic genes implicated variably; interactions reported (see gene–environment interactions entry)', 'association_context': 'candidate-gene studies'}, {'gene_or_locus': 'DNA repair genes: XRCC1, OGG1, ERCC1, XPD, XPA, XRCC3', 'variant_rsID': None, 'direction_of_effect': 'polymorphisms studied as modifiers of lung cancer risk; implicated but inconsistent across studies', 'association_context': 'candidate-gene and phenotypic DNA repair capacity studies'}, {'gene_or_locus': 'Chromosome 6q23-25 (familial linkage region)', 'variant_rsID': None, 'direction_of_effect': 'familial linkage region associated with familial lung cancer; combined with smoking history associated with ~3-fold increased risk', 'association_context': 'family linkage studies (Bailey-Wilson et al.)'}]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td>No formal PRS reported in this review; mentions multivariable risk models (Spitz model) incorporating family history and exposures but not a genome-wide PRS.</td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>Meta-analysis of 32 studies: ~2-fold increased risk for lung cancer with family history of lung cancer (present in smokers and nonsmokers); Bailey-Wilson linkage: familial region plus smoking → ~3-fold increase.</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td>Spitz risk-prediction models mentioned (incorporate smoking history, ETS, occupational exposures, family history) but no AUC or performance metrics reported in this review.</td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>['Many single-candidate polymorphism studies show mixed or conflicting results; e.g., CYP1A1 Ile462Val showed no overall significant risk in meta-analysis except in subgroup pooled analyses; GSTM1 null association attenuated when analysis limited to larger studies.']</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Inherited variation alters activation/detoxification of tobacco carcinogens, DNA repair capacity, and host responses to mutagen exposure, thereby modulating individual susceptibility to tobacco-induced carcinogenesis.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Heterogeneous study designs/populations, small sample sizes for many candidate-gene studies, publication bias, population stratification, difficulty separating genetic effects from correlated exposures (smoking intensity, occupational exposures).</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Lung cancer: epidemiology, etiology, and prevention.', 'publication_date_yy_mm': '2011-12'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e116.1">
                <h3 class="extraction-instance">Extracted Data Instance 1 (e116.1)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Gene × smoking interactions</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Specific gene–environment interactions modifying smoker risk (examples from candidate-gene studies)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The review highlights explicit gene × smoking interactions: e.g., NAT2 × mEH modifying risk by smoking dose, and familial loci interacting with smoking history to amplify risk.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>candidate-gene interaction analyses (case-control) and family linkage interaction reports (reviewed studies)</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>Examples include heavy smokers (e.g., 120 pack-year subgroup) in case-control cohorts; nonsmoker strata also examined in some reports; specific ancestry not consistently reported in review.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Pack-years used to stratify interactions (example: 120 pack-year subgroup); smoking status (never/former/current) used in some interaction analyses.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Case-control defined lung cancer (histology unspecified in interaction example in review).</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[{'gene_or_locus': 'NAT2 (acetylation phenotype)', 'variant_rsID': None, 'direction_of_effect': 'NAT2 slow-acetylation combined with mEH high-activity associated with increased risk in heavy smokers', 'association_context': 'interaction with smoking dose'}, {'gene_or_locus': 'mEH/EPHX1 (activity variants)', 'variant_rsID': None, 'direction_of_effect': 'mEH high-activity combined with NAT2 slow-acetylation increased risk in heavy smokers; in nonsmokers the same genotype combo associated with decreased risk', 'association_context': 'gene–gene × smoking interaction'}]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[{'interaction_factors': 'NAT2 slow-acetylation × mEH high-activity × heavy smoking (120 pack-years)', 'interaction_model': 'multiplicative interaction described (case-control stratified analysis)', 'summary': 'In 120 pack-year smokers with NAT2 slow-acetylation + mEH high-activity genotype, observed ~2-fold increased lung cancer risk; in nonsmokers the genotype combo associated with ~50% decreased risk.'}, {'interaction_factors': 'Familial locus on chromosome 6q23-25 × smoking', 'interaction_model': 'additive/multiplicative combination reported in family linkage context', 'summary': 'Addition of smoking history to inheritance at 6q region associated with ~3-fold increased risk.'}]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td>Not reported.</td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>Example interaction result: ~2-fold increase in lung cancer risk among 120 pack-year smokers with NAT2 slow-acetylation + mEH high-activity genotype; ~50% decreased risk among nonsmokers with same genotype combination (as reported in cited study summarized in review).</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td>No predictive performance metrics for interaction models reported.</td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Variants in metabolic-activation and detoxification enzymes alter internal dose of activated carcinogens from tobacco smoke, producing different DNA damage loads depending on smoking intensity.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Interaction studies often underpowered, potential multiple-comparison issues, heterogeneity across studies, residual confounding by exposure measurement error and other exposures.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Lung cancer: epidemiology, etiology, and prevention.', 'publication_date_yy_mm': '2011-12'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e116.2">
                <h3 class="extraction-instance">Extracted Data Instance 2 (e116.2)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Exposure/dose and internal-dose biomarkers</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Smoking exposure metrics and internal-dose biomarkers (pack-years, inhalation depth, tar/nicotine yield, cotinine, urinary carcinogen metabolites, DNA adducts)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The review emphasizes that differences in exposure intensity and internal dose (pack-years, cigarettes/day, inhalation depth, tar yield, and biomarkers such as serum cotinine, urinary carcinogen metabolites, and DNA adducts) help explain why some smokers develop lung cancer and others do not.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>epidemiologic exposure-assessment studies and biomarker measurement studies (reviewed evidence)</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>Smokers in general population cohorts and case-control series; examples include machine-measured tar/nicotine yields vs actual smoker compensation behaviors, clinical cohorts measured for urinary metabolites and DNA adducts.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Pack-years, cigarettes/day, age at initiation, duration, time since quitting, inhalation depth (qualitative), filter vs unfiltered and tar/nicotine machine yields; example cutoffs: heavy smoking (e.g., 120 pack-years) used in interaction example; household exposure in 'smoker-years' (≥25 smoker-years described for ETS childhood exposure).</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Varied across cited studies (incident lung cancer, mortality, histology-specific outcomes), as summarized in review.</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[{'marker': 'Serum cotinine', 'sample_type': 'serum', 'relationship_to_risk': 'marker of recent tobacco exposure; NHANES reported detectable cotinine in 88% of nontobacco users (exposure to ETS); used to quantify involuntary exposure'}, {'marker': 'Urinary carcinogen metabolites (machine/Hecht studies)', 'sample_type': 'urine', 'relationship_to_risk': 'measurable carcinogenic metabolites present in nonsmokers exposed to sidestream smoke; used as evidence of internal dose of tobacco carcinogens'}, {'marker': 'DNA adducts (PAH-, 4-ABP-adducts, general DNA adducts)', 'sample_type': 'lung tissue/bronchial epithelium (and sometimes blood surrogate)', 'relationship_to_risk': 'DNA adduct levels reflect internal DNA damage from tobacco carcinogens; higher adduct levels linked to increased cancer susceptibility (women reported higher levels in cited study)'}, {'marker': 'TSNAs/NNK (tobacco-specific nitrosamines measured or discussed)', 'sample_type': 'inhaled smoke delivery to lung; metabolites detectable in urine', 'relationship_to_risk': 'NNK is metabolically activated to DNA-damaging species; implicated mechanistically in adenocarcinoma induction'}]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>Exposure-related estimates summarized: long-term smokers RR ~10–30-fold vs lifetime nonsmokers; heavy smoker cumulative lung cancer risk up to ~30% vs <1% in nonsmokers; inhalation depth and compensation when smoking low-yield cigarettes implicated in increased peripheral (adenocarcinoma) exposure.</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td>No formal prediction metrics reported for biomarker-only models in this review.</td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Inter-individual differences in smoking intensity, inhalation topography, and compensation behavior alter internal dose of carcinogens; metabolic activation/detoxification and resultant DNA adduct burden vary between individuals leading to differential risk.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Machine-measured tar/nicotine yields underestimate true exposure due to smoker compensation; exposure misclassification (self-report), time-variability of biomarkers, and tissue accessibility limit causal inference.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Lung cancer: epidemiology, etiology, and prevention.', 'publication_date_yy_mm': '2011-12'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e116.3">
                <h3 class="extraction-instance">Extracted Data Instance 3 (e116.3)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>DNA repair capacity & mutagen sensitivity</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>DNA repair enzyme polymorphisms and phenotypic mutagen sensitivity as predictors of smoker susceptibility</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The review summarizes evidence that reduced DNA repair capacity and mutagen sensitivity phenotypes (plus polymorphisms in DNA repair genes) increase lung cancer risk among smokers and may interact with smoking exposure.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>phenotypic DNA repair capacity studies, candidate-gene association studies (review)</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>Case-control and cohort studies that measured DNA repair capacity or genotyped DNA repair gene polymorphisms in smokers and nonsmokers; populations not homogenized in review.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Adjusted for smoking status and pack-years in underlying studies; mutagen sensitivity studies often stratified by smoking.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Case-control/histology-confirmed lung cancer in cited studies.</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[{'gene_or_locus': 'XRCC1, OGG1 (base excision repair)', 'variant_rsID': None, 'direction_of_effect': 'polymorphisms associated variably with risk; evidence cited but inconsistent'}, {'gene_or_locus': 'ERCC1, XPD, XPA (nucleotide excision repair)', 'variant_rsID': None, 'direction_of_effect': 'polymorphisms studied for association with lung cancer susceptibility'}, {'gene_or_locus': 'XRCC3 (double-strand break repair)', 'variant_rsID': None, 'direction_of_effect': 'studied as potential modifier'}]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[{'marker': 'DNA adduct levels', 'sample_type': 'lung/bronchial tissue or surrogate tissues', 'relationship_to_risk': 'Higher DNA adduct levels associated with increased lung cancer risk and linked to deficient DNA repair or high activation genotypes'}]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[{'measure': 'Mutagen sensitivity assays / DNA repair capacity phenotyping', 'relationship_to_risk': 'Mutagen sensitivity phenotype associated with increased lung cancer risk; combined effect with smoking greater than either alone (Spitz et al. cited).'}]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>Spitz et al. review: combined risk for lung cancer greater in individuals with mutagen sensitivity who smoked than in those with either risk factor alone (no single pooled OR provided in review).</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td>No AUC or discrimination metrics reported for DNA repair-based models in this review.</td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>Individual DNA repair gene polymorphism studies are inconsistent and not definitive.</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Impaired repair of tobacco-induced DNA adducts allows fixation of mutations, increasing carcinogenesis risk among smokers with low repair capacity.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Phenotypic assays variable across labs, potential reverse causation if assays conducted after cancer diagnosis, small samples in many studies, genotype–phenotype discordance.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Lung cancer: epidemiology, etiology, and prevention.', 'publication_date_yy_mm': '2011-12'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e116.4">
                <h3 class="extraction-instance">Extracted Data Instance 4 (e116.4)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Epigenetic & transcriptomic markers</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Epigenetic alterations and gene-expression 'field of injury' signatures associated with smoker risk</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The review notes acquired epigenetic changes (DNA methylation, histone modification) and transcriptomic differences between lung cancers in smokers and never-smokers; microarray profiling shows heterogeneity and distinct profiles that may underlie differential susceptibility.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>molecular profiling (microarray) and epigenetic studies (reviewed evidence)</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>Tumor tissue and airway epithelial sampling from smokers and never smokers; specific cohorts not detailed in review.</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Smoking status (never vs smoker) used to stratify molecular profiles; exposure dose not universally reported.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Histology-defined lung adenocarcinoma and other subtypes; molecular profiling compared cases by smoking status.</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[{'marker': 'DNA methylation & histone modifications', 'sample_type': 'tumor and presumably airway epithelium (general mention)', 'reported_performance': None, 'notes': 'Authors list DNA methylation and histone deacetylation/phosphorylation as acquired epigenetic events that can modulate susceptibility; no specific loci or predictive performance provided in review.'}, {'marker': 'Microarray gene-profiling signatures (smokers vs never-smokers)', 'sample_type': 'tumor tissue (adenocarcinoma)', 'reported_performance': None, 'notes': 'Profiles differ by smoking status, supporting biological heterogeneity between smoker and never-smoker lung cancers.'}]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>No quantitative predictive metrics provided; statements are descriptive that never-smoker and smoker tumors have distinct molecular signatures.</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td>Not reported in review.</td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Epigenetic changes from tobacco exposure may alter gene expression programs predisposing to malignant transformation (field cancerization); differences in methylation/expression may explain differential susceptibility.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Heterogeneity of profiling platforms, lack of large prospective validation cohorts, potential confounding by tumor histology and stage.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Lung cancer: epidemiology, etiology, and prevention.', 'publication_date_yy_mm': '2011-12'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e116.5">
                <h3 class="extraction-instance">Extracted Data Instance 5 (e116.5)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Preexisting lung disease & inflammation</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Comorbid lung disease (COPD, airflow obstruction, pulmonary fibrosis) and inflammatory markers as modifiers of smokers' lung cancer risk</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The review emphasizes that COPD and other chronic lung diseases (including idiopathic pulmonary fibrosis and α1-antitrypsin carrier status) and chronic inflammation (e.g., elevated CRP) are associated with substantially higher lung cancer risk among smokers and may partly explain inter-individual variability.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>cohort studies, case-control studies, Lung Health Study, registry analyses (reviewed evidence)</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>Smokers with spirometrically defined COPD enrolled in Lung Health Study and other cohorts; studies include large smoker cohorts and lung cancer patients (e.g., a 602-patient study evaluating COPD prevalence in lung cancer).</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Adjusted for smoking history; many analyses consider pack-years and smoking status; COPD diagnoses based on spirometry (prebronchodilator values) in cited studies.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Incident lung cancer and lung cancer mortality in cohorts and case-control comparisons; some studies consider newly diagnosed lung cancer patients and matched smoker controls.</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[{'condition': 'COPD / airflow obstruction', 'evidence': 'COPD prevalent in 40–70% of lung cancer patients; Lung Health Study found lung cancer the most common cause of death in that COPD smoker cohort; one study of 602 lung cancer patients found 50% had spirometric COPD and an OR of 11.6 (independent of age/gender/smoking history) compared with matched smokers.', 'interpretation': 'COPD is an independent and strong risk factor for lung cancer among smokers'}, {'condition': 'Idiopathic pulmonary fibrosis (cryptogenic fibrosing alveolitis)', 'evidence': 'Cohort of 890 patients vs controls: OR for lung cancer = 8.25 after adjustment for smoking.', 'interpretation': 'Pulmonary fibrosis markedly increases lung cancer risk independent of smoking'}, {'condition': 'α1-antitrypsin deficiency carrier status', 'evidence': 'Case-control/parallel cohort analysis: carriers had ~2-fold increased lung cancer risk after adjusting for smoking and COPD.', 'interpretation': 'Genetic predisposition to emphysema/inflammation increases risk'}, {'marker': 'C-reactive protein (CRP)', 'evidence': 'Dutch study: CRP >3 mg/L associated with increased likelihood of developing lung cancer compared to <1 mg/L', 'interpretation': 'Systemic inflammation marker associated with higher risk'}]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>Selected estimates: COPD association example OR = 11.6 (study of 602 patients); idiopathic pulmonary fibrosis OR = 8.25; α1-antitrypsin carriers ~2-fold increased risk; CRP >3 mg/L associated with increased lung cancer likelihood (no numeric HR provided in review).</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td>No formal prediction performance metrics reported that combine COPD or inflammation with smoking to stratify risk.</td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Chronic inflammation and repeated epithelial injury/repair in COPD and fibrotic lung disease may promote carcinogenesis (field effect); impaired clearance of carcinogens and local pro-oncogenic inflammatory milieu are hypothesized mechanisms.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Confounding by smoking exposure (smokers are more likely to have COPD), potential overdiagnosis of COPD in lung cancer patients, reverse causation if lung cancer affects spirometry, and variable adjustment for smoking intensity in studies.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Lung cancer: epidemiology, etiology, and prevention.', 'publication_date_yy_mm': '2011-12'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e116.6">
                <h3 class="extraction-instance">Extracted Data Instance 6 (e116.6)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Behavioral, social & environmental modifiers</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Smoking behavior, socioeconomic factors, occupational and environmental exposures, diet and BMI as modifiers of risk among smokers</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The review details non-genetic modifiers of smoker risk: dose/duration/inhalation/topography, socioeconomic and regional differences, occupational carcinogens (asbestos, diesel, radon), secondhand smoke, air pollution, biomass/wood-smoke exposure, diet (fruit/vegetable intake and β-carotene trial results), and BMI associations.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>epidemiologic cohort and case-control studies, randomized trials (for dietary supplements), occupational cohort studies, meta-analyses (reviewed evidence)</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>Various populations: large cohorts (e.g., Cancer Prevention Study II), occupational cohorts (trucking industry, asbestos-exposed workers), international populations for biomass/coal smoke studies (China, Europe).</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Pack-years, cigarettes-per-day, age at initiation, tar/nicotine yield, filter use, inhalation depth; ETS measured as spouse smoking, smoker-years (household smoker-years).</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Incident lung cancer, lung cancer mortality, histology-specific outcomes in multiple cited studies.</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>[{'modifier': 'Smoking intensity and duration (pack-years, cigarettes/day, age at initiation)', 'evidence': 'Strong dose–response: relative risk of long-term smokers estimated 10–30× vs lifetime nonsmokers; cumulative lung cancer risk in heavy smokers up to ~30%.'}, {'modifier': 'Depth of inhalation and compensation (low-yield/filtered cigarettes)', 'evidence': 'Deeper inhalation and compensation when smoking lower-yield cigarettes may deliver smoke to peripheral lung and linked to rise in adenocarcinoma; discussed as mechanism rather than quantified effect size.'}, {'modifier': 'Secondhand (environmental) tobacco smoke (ETS)', 'evidence': 'Pooled OR ≈1.34 (NRC review); ACS cohort reported RR ≈1.2 for women with smoking husbands; household high-level childhood exposure (≥25 smoker-years) doubled risk in one study.'}, {'modifier': 'Occupational carcinogens (asbestos, diesel, arsenic, chromium, nickel, silica, vinyl chloride etc.)', 'evidence': 'Estimated 10% of lung cancer deaths among men and 5% among women worldwide attributable to 8 occupational carcinogens; diesel exhaust occupational exposure ~30–50% increased risk in meta-analyses.'}, {'modifier': 'Ambient air pollution (fine particulates PM2.5)', 'evidence': 'Major US cohorts: ~8–19% increased lung cancer mortality per 10 μg/m3 increment in long-term PM exposure (Pope et al., Dockery et al. summarized).'}, {'modifier': 'Biomass/coal/wood smoke', 'evidence': 'Household coal combustion classified as human carcinogen by IARC; predominant coal use OR 1.64 overall and OR 4.93 in Asia reported in consortium data; wood users OR ~1.21 in some regions.'}, {'modifier': 'Diet & supplements (β-carotene trials)', 'evidence': 'ATBC and CARET randomized trials found β-carotene supplementation increased lung cancer incidence/mortality in high-risk smokers; observational data suggest fruits/vegetables protective but RCTs negative/harmful for β-carotene supplements.'}, {'modifier': 'BMI', 'evidence': 'Inverse association between BMI and lung cancer in smokers in meta-analyses and cohorts (potentially confounded by smoking); in never-smokers BMI positively associated in some analyses.'}]</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>Selected effect sizes: ETS pooled OR ≈1.34 (≈30% increase); spouse-smoking RR ≈1.2 (women) in ACS prospective evaluation; air pollution: ~8–19% increase in lung cancer mortality per 10 μg/m3 PM; diesel exhaust occupational RR increased ~30–50%; coal use OR 1.64 overall and OR 4.93 in Asia (consortium data).</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td>Spitz risk model includes many behavioral/environmental modifiers but review provides no discrimination metrics.</td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>['Observational protective associations for β-carotene were not borne out in RCTs; RCTs (ATBC, CARET) showed no benefit and possible harm from β-carotene supplementation.']</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Higher external exposure (dose), inhalation topography delivering carcinogens to susceptible lung regions, co-exposures (occupational/air pollution/biomass), and nutritional/inflammatory status modify carcinogen effects and DNA damage fixation.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Residual confounding by cigarette smoking intensity, measurement error in exposure variables (self-report, machine yields), geographic and socioeconomic heterogeneity, and potential reverse causation in observational diet studies.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Lung cancer: epidemiology, etiology, and prevention.', 'publication_date_yy_mm': '2011-12'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e116.7">
                <h3 class="extraction-instance">Extracted Data Instance 7 (e116.7)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Tumor molecular features (smoking-related)</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Somatic tumor features linked to smoking-related carcinogenesis (KRAS, TP53, EGFR, mutational hotspots, DNA adduct-related mutations)</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>The review describes somatic mutations and pathways driven by tobacco carcinogens (e.g., NNK-associated KRAS activation, PAH-induced p53 mutations), differing mutation patterns in smokers vs never-smokers, and increased EGFR mutations in never-smoker adenocarcinomas (especially Asian populations).</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td></td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>mention</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>molecular pathology and mechanistic animal/model studies and human tumor sequencing (reviewed literature)</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>Human lung tumor series and experimental animal models; human findings include proportions of mutations in adenocarcinomas and differences by smoking status and geography (e.g., Asian cohorts showing higher EGFR mutation frequency in never smokers).</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Stratified by smoking status (never vs smoker) and sometimes by intensity; specific exposure metrics varied by underlying studies.</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Somatic mutation prevalence in histologically defined tumors (adenocarcinoma, squamous cell carcinoma, SCLC).</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[{'feature': 'KRAS-activating mutations', 'prevalence': 'KRAS activation detected in ~24% of human lung adenocarcinomas (review cites)', 'relation_to_smoking': 'Associated with NNK tobacco carcinogen; often found in smokers/ex-smokers'}, {'feature': 'TP53 mutations', 'prevalence': 'P53 abnormalities in ~60% of primary lung cancer cases (per review)', 'relation_to_smoking': 'Benzo[a]pyrene metabolites target p53 loci leading to characteristic mutations'}, {'feature': 'EGFR mutations', 'prevalence': 'Increased frequency in lung adenocarcinomas of never smokers, particularly in Asian cohorts', 'relation_to_smoking': 'Enriched in never-smokers; molecular distinction from smoking-related tumors'}]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>KRAS mutations in ~24% of adenocarcinomas; p53 abnormalities ~60% of primary lung cancers; EGFR mutation enrichment in never-smoker adenocarcinomas (regional cohorts noted).</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td>Not reported for tumor-feature based prediction of which smokers will develop cancer.</td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td>Specific tobacco carcinogens create characteristic DNA adducts leading to signature mutations (e.g., NNK→KRAS, benzo[a]pyrene→TP53), and differing somatic mutation spectra explain varying carcinogenic pathways between smokers and never-smokers.</td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Tumor sampling bias, interplay with host genetics, and geographic/ethnic variation in mutation frequencies limit direct extrapolation to predict individual susceptibility.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Lung cancer: epidemiology, etiology, and prevention.', 'publication_date_yy_mm': '2011-12'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
            <div class="extraction-instance-container" id="e116.8">
                <h3 class="extraction-instance">Extracted Data Instance 8 (e116.8)</h3>
                <div class="extraction-query"><strong>Extraction Query:</strong> Extract any mentions of factors that explain inter-individual variation in lung cancer risk among smokers (i.e., why only some smokers develop lung cancer), including genetic susceptibility, gene–environment interactions, exposure/dose metrics, comorbid lung disease, molecular/epigenetic biomarkers, and study-reported effect sizes comparing higher- vs lower-risk smoker subgroups.</div>
                <table>
                    <thead>
                        <tr>
                            <th style="width: 30%;">Field</th>
                            <th style="width: 70%;">Value</th>
                        </tr>
                    </thead>
                    <tbody>
                        <tr>
                            <td><strong>name_short</strong></td>
                            <td>Quantitative risk estimates & notable effect sizes</td>
                        </tr>
                        <tr>
                            <td><strong>name_full</strong></td>
                            <td>Key quantitative effect sizes from the review relevant to differential smoker risk</td>
                        </tr>
                        <tr>
                            <td><strong>brief_description</strong></td>
                            <td>Concise compilation of the main numerical effect estimates the review provides to illustrate inter-individual variation in lung cancer risk among smokers and related modifiers.</td>
                        </tr>
                        <tr>
                            <td><strong>citation_title</strong></td>
                            <td>here</td>
                        </tr>
                        <tr>
                            <td><strong>mention_or_use</strong></td>
                            <td>use</td>
                        </tr>
                        <tr>
                            <td><strong>study_type</strong></td>
                            <td>summary of epidemiologic effect estimates (review)</td>
                        </tr>
                        <tr>
                            <td><strong>population_description</strong></td>
                            <td>General population smokers and referenced cohorts/case-control studies summarized in the review (international).</td>
                        </tr>
                        <tr>
                            <td><strong>smoking_exposure_metrics</strong></td>
                            <td>Various (pack-years, heavy smokers, long-term smokers, spouse smoking, PM2.5 increments).</td>
                        </tr>
                        <tr>
                            <td><strong>lung_cancer_outcome_definition</strong></td>
                            <td>Incident lung cancer and lung cancer mortality as used in cited studies; mixed ascertainment.</td>
                        </tr>
                        <tr>
                            <td><strong>host_genetic_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>gene_environment_interactions</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>polygenic_or_risk_scores</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>carcinogen_metabolism_biomarkers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>dna_repair_and_genomic_stability_factors</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>epigenetic_and_transcriptomic_markers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>preexisting_lung_disease_and_inflammation</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>behavioral_and_social_modifiers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>tumor_molecular_features_in_smokers</strong></td>
                            <td>[]</td>
                        </tr>
                        <tr>
                            <td><strong>risk_estimates_key_results</strong></td>
                            <td>Summary of key numbers from review: 'One in 9 smokers eventually develops lung cancer' (~11%); relative risk in long-term smokers ~10–30× vs lifetime nonsmokers; cumulative risk in heavy smokers up to ~30% vs <1% in nonsmokers; family history meta-analysis: ~2× increased risk; GSTM1 null: ~17–18% increased risk in older meta-analyses (attenuated in larger studies); CYP1A1 Ile462Val: pooled 55% increased risk for squamous cell carcinoma in whites in pooled analyses; NAT2×mEH in 120 pack-year smokers: ~2× increased risk; Cancer Prevention Study II: RR for lung cancer in women smokers 11.94 vs men 22.36 (intensity-adjusted); Canadian case-control (40 pack-years): OR women 27.9 vs men 9.6; ETS pooled OR ≈1.34; spouse-smoking RR ≈1.2 (women); PM2.5: ~8–19% increased lung cancer mortality per 10 μg/m3; coal use OR 1.64 overall (OR 4.93 in Asia for coal users).</td>
                        </tr>
                        <tr>
                            <td><strong>predictive_model_performance</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>negative_or_null_findings</strong></td>
                            <td>['β-carotene supplementation trials (ATBC, CARET) found increased lung cancer incidence and mortality in supplemented high-risk groups (harm rather than protective effect).']</td>
                        </tr>
                        <tr>
                            <td><strong>proposed_mechanistic_explanations</strong></td>
                            <td><span class="empty-note">null</span></td>
                        </tr>
                        <tr>
                            <td><strong>limitations_and_confounders</strong></td>
                            <td>Heterogeneity of underlying studies, differing exposure definitions, residual confounding by smoking intensity, and subgroup analyses that may be underpowered or exploratory.</td>
                        </tr>
                        <tr>
                            <td><strong>source_info</strong></td>
                            <td>{'paper_title': 'Lung cancer: epidemiology, etiology, and prevention.', 'publication_date_yy_mm': '2011-12'}</td>
                        </tr>
                    </tbody>
                </table>
            </div>
        </div>

        <div class="section">
            <h2>Potentially Relevant New Papers (mentioned by this paper)</h2>
            <ol>
                <li>Alpha-Tocopherol, Beta Carotene Cancer Prevention (ATBC) Study <em>(Rating: 2)</em></li>
                <li>Beta-Carotene and Retinol Efficacy Trial (CARET) <em>(Rating: 2)</em></li>
                <li>American Cancer Society Cancer Prevention Study II <em>(Rating: 2)</em></li>
                <li>Lung Health Study <em>(Rating: 2)</em></li>
            </ol>
        </div>

        </div>

    </div>
</body>
</html>